The Vanguard Group 13D/13G Filings for Kindred Biosciences, Inc. (KIN)

The Vanguard Group 13D and 13G filings for Kindred Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
11:10 am
Purchase
2020-12-31 13G Kindred Biosciences, Inc.
KIN
The Vanguard Group 1,983,025
5.030%
1,983,025increase
(New Position)
Filing